H.E.L Group has announced the expansion of its BioXplorer range with two new automated parallel bioreactors: the BioXplorer 400XL and BioXplorer 400P. These bioreactors are designed to enhance the development and optimisation of bioprocesses cost-effective.

The BioXplorer 400P is specifically built to operate at pressures up to 10 bar, enabling higher cell density and increased product yields. It is particularly suitable for syngas fermentation and allows complete control of four high-pressure bioprocesses simultaneously through user-friendly software and modular hardware.

On the other hand, the BioXplorer 400XL features eight configurable bioreactors that can be controlled independently or in parallel. Its modular design facilitates accurate liquid and gas additions, with the ability to control up to four sets of peristaltic pumps and up to two sets of mass flow controllers. The bioreactor system supports enhanced cell densities and product yield by handling magnetic or direct agitation.

The H.E.L bioreactor systems offer a comprehensive range of automated, parallel experimentation options, ranging from 50 mL to 5 L in size. These systems find applications in gas fermentation research and bench-scale bio-production. They are particularly suitable for small-scale process development, cell line/strain screening, and optimization investigations.

Louise Madden, CEO of H.E.L Group, said “Our flexible bioreactor systems help our customers gain more knowledge about their bioprocesses earlier in their development and so make better decisions, resulting in bioprocess development which is faster and more productive. The introduction of the new BioXplorer 400P and BioXplorer 400XL further increases our automated parallel bioreactor offering, doubling volume capabilities with highly configurable and readily upgradable systems.”